Hodgkin lymphoma in the Swiss HIV Cohort Study

Blood

Volumn 113, Issue 23, 2009, Pages 5737-5742

  Clifford, Gary M ^a   Rickenbach, Martin ^b   Lise, Mauro ^c   Dal Maso, Luigino ^c   Battegay, Manuel ^d   Bohlius, Julia ^e   El Amari, Emmanuelle Boffi ^f   Karrer, Urs ^g   Jundt, Gernot ^h   Bordoni, Andrea ⁱ   Ess, Silvia ^j   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Swiss HIV Cohort Study   (Switzerland)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h Cancer Registry of Basel   (Switzerland)

ⁱ Cancer Registry of the Canton of Ticino   (Switzerland)

^j Cancer Registry of St Gallen and Appenzell   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONFIDENCE INTERVAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; SWITZERLAND; FEMALE; IMMUNOLOGY; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; SWITZERLAND;

EID: 67651121934     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-204172     Document Type: Article

References (35)

1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/ AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370:59-67.
2. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432. (Pubitemid 40528605)
3. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745. (Pubitemid 32259908)
4. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer. 2003;89:94-100.
5. Allardice GM, Hole DJ, Brewster DH, Boyd J, Goldberg DJ. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer. 2003;89:505-507. (Pubitemid 37026434)
6. Newnham A, Harris J, Evans HS, Evans BG, Moller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer. 2005;92:194-200. (Pubitemid 40188455)
7. Grulich AE, Li Y, McDonald A, et al. Rates of non- AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002; 16:1155-1161. (Pubitemid 34533854)
8. Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006;118:985-990. (Pubitemid 43157675)
9. Galceran J, Marcos-Gragera R, Soler M, et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer. 2007;43:1085-1091. (Pubitemid 46505101)
10. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-3453. (Pubitemid 46594077)
11. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645-1654.
12. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123: 187-194. (Pubitemid 351705208)
13. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non- AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-1153. (Pubitemid 47233717)
14. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100:840-847.
15. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791.
16. Gloghini A, Carbone A. Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity? Int J Cancer. 2007;120:2753-2754.
17. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9:15-27.
18. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148:728-736.
19. Breslow NE, Day NE. Statistical Methods in Cancer Research: The Design and Analysis of Cohort Studies, Vol 2 [International Agency for Research on Cancer scientific publication 82]. Lyon, France: International Agency for Research on Cancer; 1987.
20. Cox DR. Regression models and life-time tables. J Royal Stat Soc B. 1972;34:187-220.
21. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed). Lyon, France: International Agency for Research on Cancer; 2008.
22. Thompson LD, Fisher SI, Chu WS, Nelson A, Abbondanzo SL. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol. 2004; 121:727-738. (Pubitemid 38534005)
23. Hoffmann C, Chow KU, Wolf E, et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol. 2004;125:455-462. (Pubitemid 38916190)
24. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339:1506-1514.
25. Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. J Clin Oncol. 2005;23:5739-5745. (Pubitemid 46321305)
26. Morton LM,Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265-276.
27. Polesel J, Clifford GM, Rickenbach M, et al. Non- Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS. 2008;22:301-306.
28. Fontas E, Kousignian I, Pradier C, et al. Interleukine 2 therapy does not increase the risk of Hodgkin's or non-Hodgkin's lymphoma in HIVinfected patients: results from FHDH ANRS CO4. J Acquir Immune Defic Syndr. 2009;50:206-214.
29. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Vol 9 [International Agency for Research on Cancer scientific publication 160]. Lyon, France: International Agency for Research on Cancer; 2007.
30. Franceschi S, Dal Maso L, Rickenbach M, et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer. 2008;99:800-804. (Pubitemid 352015643)
31. Bosch PR, Lejeune M, Salvado Usach MT, et al. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma. Ann Hematol. 2005;84:661-666. (Pubitemid 41554242)
32. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431. (Pubitemid 27169287)
33. Kaech SM, Ahmed R. Immunology: CD8 T cells remember with a little help. Science. 2003;300: 263-265. (Pubitemid 36433703)
34. Piriou E, van DK, Nanlohy NM, et al. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood. 2005;106:3166-3174. (Pubitemid 41565915)
35. Gasser O, Bihl FK,Wolbers M, et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med. 2007;4:e96. (Pubitemid 46495323)